Earnings NYSE Nasdaq 100 U.S. Tech Politics Science AI SEC Business Wall Street Energy Dow Jones Dividend Bitcoin (BTC) Markets NVIDIA (NVDA) Investing Economy S&P 500 China Donald Trump Fed World Crude Oil Tesla (TSLA) Money Inflation Gold Software Apple (AAPL) U.K. Wealth Entertainment Health Amazon (AMZN) Retail 3M (MMM) Real Estate Taxes Europe Natural Gas Elon Musk Microsoft (MSFT) Security Meta Platforms (META) Retirement Truist Financial Corp (TFC) Canada Current Boeing (BA) Options Jim Cramer Hedge Funds Insurance Tax Sports Live Google Economics Manufacturing Pharmaceuticals Cars Mining Costco (COST) Airlines Warren Buffett War Japan Silver Construction Interest Rates Ukraine York BlackRock (BLK) New York Holidays Kamala Harris Finance Goldman Sachs (GS) REITs Space Mortgage KeyCorp (KEY) Internet Walmart (WMT) Aerospace JPMorgan (JPM) Ethereum (ETH) Intel (INTC) Walt Disney (DIS) Enterprise OpenAI ChatGPT GBP USD Netflix (NFLX) Australia Boston Morgan Stanley (MS) IndiaMore +
Market Insider Market Insider
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

2 days Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain InexpensiveSeeking Alpha

Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive.

Johnson & Johnson (JNJ)

X       

17 hours J&J Loses Around $24B in a Month: How to Play the Stock?Zacks X       

1 day 1 Dividend King at a 52-Week Low and Another at a 52-Week High to Buy NowThe Motley Fool X       

2 days Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should KnowZacks X       

3 days Johnson & Johnson (JNJ) Management presents at Stifel 2024 Healthcare Conference (Transcript)Seeking Alpha X       

3 days CHMP Endorses J&J’s Rybrevant-Lazcluze Combo for Use in NSCLCZacks X       

6 days Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting ProgramYahoo Finance X       

7 days J&J; Snack Foods (JJSF) Q4 2024 Earnings Call TranscriptThe Motley Fool X       

7 days Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report?Zacks X       

1 week Compared to Estimates, J&J Snack Foods (JJSF) Q4 Earnings: A Look at Key MetricsZacks X       

3 weeks Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.2% – Time to Sell?MarketBeat X       

3 weeks Johnson & Johnson (NYSE:JNJ) Sees Significant Drop in Short InterestMarketBeat X       

3 weeks The Zacks Analyst Blog Highlights Amazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of DistinctionZacks X       

3 weeks Top Stock Reports for Amazon.com, Johnson & Johnson and Boston ScientificZacks X       

3 weeks Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.2% – Still a Buy?MarketBeat X       

3 weeks J&J Snack Foods (NASDAQ:JJSF) Earns Buy Rating from BenchmarkMarketBeat X       

3 weeks Johnson & Johnson (NYSE:JNJ) Shares Sold by State of Alaska Department of RevenueMarketBeat X       

3 weeks Johnson & Johnson (NYSE:JNJ) Trading Up 0.5% – What’s Next?MarketBeat X       

3 weeks Allworth Financial LP Boosts Position in Johnson & Johnson (NYSE:JNJ)MarketBeat X       

4 weeks Commonwealth Financial Services LLC Has $584,000 Stake in Johnson & Johnson (NYSE:JNJ)MarketBeat X       

4 weeks Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.7% – Here’s What HappenedMarketBeat X       

4 weeks Johnson & Johnson (NYSE:JNJ) Shares Acquired by Sequoia Financial Advisors LLCMarketBeat X       

4 weeks This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly’s StockThe Motley Fool X       

4 weeks Johnson & Johnson (NYSE:JNJ) Trading Down 0.1% – Here’s WhyMarketBeat X       

1 month Border to Coast Pensions Partnership Ltd Raises Position in Johnson & Johnson (NYSE:JNJ)MarketBeat X       

1 month The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and SanofiZacks X       

1 month Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.8% – Here’s WhyMarketBeat X       

1 month Kenvue shares surge after activist Starboard takes stakeCNBC X       

1 month J&J’s Ketamine-Derived Drug Is Taking OffThe Wall Street Journal X       

1 month Johnson & Johnson (NYSE:JNJ) Shares Sold by Claro Advisors LLCMarketBeat X       

1 month Starboard Value takes stake in JNJ spin-off Kenvue- WSJInvesting.com X       

1 month Activist Starboard Value Takes Stake in Tylenol-Maker KenvueThe Wall Street Journal X       

1 month Allspring Global Investments Holdings LLC Raises Stake in J&J Snack Foods Corp. (NASDAQ:JJSF)MarketBeat X       

1 month Johnson & Johnson: Q3 Earnings Highlights Resilience And New GrowthSeeking Alpha X       

More news +
Home | Contact
  • X

© 2024 Market Insider